Schedule 13G ownership disclosure
THERIVA BIOLOGICS INC
Common stock · CUSIP: 87164U508
Event date: 2025-10-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Jeffrey Matthew Gryga Irrevocable Trust
Shares: 739,211.00 · Class: 7.7%
- Gryga Jeffrey Matthew
Shares: 739,211.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002096075-25-000001
- Form type
- SCHEDULE 13G
- Filer
- Jeffrey Matthew Gryga Irrevocable Trust
- CIK
- CIK 2096075
- Filed
- Nov 10, 2025
- Reporting period
- Oct 24, 2025
- Description
- Schedule 13G beneficial ownership